Abstract
Objectives A key measure to mitigate coronavirus disease 2019 (COVID-19) has been social distancing. Incorporating video-conferencing applications in the patient handover process between healthcare workers can enhance social distancing while maintaining handover elements. This study describes pediatric intensive care unit (PICU) physicians’ experience of using an online video-conferencing application for handover during the COVID-19 pandemic. Design: qualitative content analysis
Setting PICU at a university hospital in Riyadh, Saudi Arabia Subjects: PICU Physicians
Interventions Due to the pandemic, the hospital’s PICU used Zoom® as a remote conferencing application, instead of a face-to-face handover. Following institutional review board approval, data were collected over two weeks (July 1, 2020 to July 14, 2020). Measurements: Demographic data and narrative descriptions of the perceived efficacy of remote handover were collected using open-ended questions through a created online link. The analysis process included open coding, creating categories, and abstraction.
Main Results All 37 PICU physicians who participated in the handover completed the survey. The participants comprised six attendings, nine specialists, and 22 residents. They had variable previous teleconferencing experiences. Most physicians (78.4%) were comfortable conducting a remote endorsement. Most found that Situation–Background– Assessment–Recommendation handover elements were properly achieved through this remote handover process. The perceived advantages of online handover included fewer interruptions, time efficiency, and facilitation of social distancing. The perceived disadvantages were the paucity of nonverbal communication and teaching during virtual meetings.
Conclusions Video-conferencing applications used for online handovers could supplement traditional face-to-face intensive care unit patient endorsement during outbreaks of infectious diseases. The use of video streaming and more emphasis on teaching should be encouraged to optimize the users’ experience.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors are grateful to the Deanship of Scientific Research, King Saud University, for funding through the Vice Deanship of Scientific Research Chairs.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the institutional review board of King Saud University, Riyadh, Saudi Arabia (approval # 20/0553/IRB).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the data for this study will be made available upon reasonable request.
Abbreviations
- CDC
- Centers for Disease Control and Prevention
- COVID-19
- coronavirus disease 2019
- ICU
- Intensive care unit
- KSUMC
- King Saud University Medical City
- MDC
- multidisciplinary conference
- PCR
- polymerase chain reaction
- PICU
- pediatric intensive care unit
- PPE
- personal protective equipmentSARS-CoV-2, severe acute respiratory syndrome coronavirus 2
- WHO
- World Health Organization